Malignant News and Research

RSS

Study traces the natural evolution of earliest stages of human cancers

Cancer cells-to-be accumulate a series of specific genetic changes in a predictable and sequential way years before they are identifiable as pre-malignancies, researchers at Stanford Medicine have found.

7 Jul 2023

AI tool can rapidly decode brain tumor DNA during surgery

Scientists have designed an AI tool that can rapidly decode a brain tumor's DNA to determine its molecular identity during surgery -; critical information that under the current approach can take a few days and up to a few weeks.

7 Jul 2023

Researchers show how communication networks in the tumor microenvironment promote cancer growth

Tumors consist of both the actual, malignant cancer cells and healthy, non-transformed cells in the immediate environment.

7 Jul 2023

Aneuploidy could function as a therapeutic target for cancer

Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming tumors.

6 Jul 2023

Two decade Taiwan study reveals mild link between mobile phone usage and brain cancer incidence

Study explores the limitations and variables affecting the incidence of brain tumors and mortality in mobile phone users, highlighting the need for a comprehensive analysis of factors such as radiation exposure, genetics, and lifestyle. Recommendations for precautionary measures to ensure population health.

5 Jul 2023

Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical advisory board to help the company advance its 3D genomics technologies into the clinical oncology and biopharmaceutical markets.

From Arima Genomics, Inc. 5 Jul 2023

Mutations in AGC kinase motif linked to colorectal cancer growth

Cancer spreads throughout the human body in cunning, almost militaristic, ways. For example, it can manipulate our genetic make-up, take over specific cell-to-cell signaling processes, and mutate key enzymes to promote tumor growth, resist therapies, and hasten its spread from the original site to the bloodstream or other organs.

3 Jul 2023

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Jul 2023

Skipping nightly toothbrushing could heighten cardiovascular disease risk

Research investigated the impact of toothbrushing timing on cardiovascular disease risk. The study found that brushing teeth at night was associated with lower cardiovascular disease risk compared to not brushing at all.

2 Jul 2023

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis.

28 Jun 2023

AI algorithm with high diagnostic accuracy helps improve lung cancer detection

Assistance from an artificial intelligence (AI) algorithm with high diagnostic accuracy improved radiologist performance in detecting lung cancers on chest X-rays and increased human acceptance of AI suggestions, according to a study published in Radiology, a journal of the Radiological Society of North America.

27 Jun 2023

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Study describes the use of engineered commensal bacteria to increase antitumor immunity.

23 Jun 2023

Study finds new way to predict therapy response in metastatic renal cell carcinoma

Dr. Niklas Klümper, resident at the Department of Urology and Pediatric Urology of the University Hospital Bonn (UKB) and working group leader at the Institute for Experimental Oncology (IEO), and Dr. Jonas Saal, resident at the Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology of the UKB, demonstrated a significant improvement in predicting the response to therapy in metastatic renal cell carcinoma by incorporating the level of inflammation, which was assessed using two straightforward blood parameters, alongside the conventional imaging-based approach.

22 Jun 2023

Parental cancer history associated with critical unmet needs of children

A new study by researchers at the American Cancer Society (ACS) found children of parents with a cancer history in the United States are more at risk of having unmet needs for housing, food, and other living necessities than their counterparts without a parental cancer history.

22 Jun 2023

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

21 Jun 2023

Researchers develop a prediction tool for blood cancer therapies

Since its introduction in 2015, a prediction tool developed by the European Society of Medical Oncology has been providing support worldwide in the assessment of the clinical benefits of new cancer therapies.

20 Jun 2023

New and significant breakthrough made to detect brain tumors

Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to detect folate receptors in brain tumors.

15 Jun 2023

Analyzing the role of ACSL4 in quadruple negative breast cancer

A new review paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "ACSL4: biomarker, mediator and target in quadruple negative breast cancer."

15 Jun 2023

Revolution in neuroscience: 2D nanomaterials propel advances in brain repair, treatment, and diagnosis

Review discusses the increasing importance of two-dimensional nanomaterials like graphene in neuroscience, highlighting their potential in nerve repair, creating brain-mimicking synaptic devices, and treating neurological disorders. It also considers the challenges and future prospects of these materials in this complex field.

11 Jun 2023

Cost of prescription drugs to the NHS reached a new high in the financial year 2021 -2022, says LSE report

New figures show that the total cost of prescription medicines to the NHS in England reached a new high of £17.2 billion in the financial year 2021 -2022, according to a new independent report by the London School of Economics and Political Science (LSE), the London School of Hygiene & Tropical Medicine and the University of York.

4 Jun 2023

Malignant News and Research

Study traces the natural evolution of earliest stages of human cancers

AI tool can rapidly decode brain tumor DNA during surgery

Researchers show how communication networks in the tumor microenvironment promote cancer growth

Aneuploidy could function as a therapeutic target for cancer

Two decade Taiwan study reveals mild link between mobile phone usage and brain cancer incidence

Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Mutations in AGC kinase motif linked to colorectal cancer growth

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

Skipping nightly toothbrushing could heighten cardiovascular disease risk

Novel anti-cancer drug found to sensitize tumor cells to ferroptosis

AI algorithm with high diagnostic accuracy helps improve lung cancer detection

The use of bacterial colonists as therapy carriers is gaining interest for treating cancer

Study finds new way to predict therapy response in metastatic renal cell carcinoma

Parental cancer history associated with critical unmet needs of children

Study reveals why some women with deadly ovarian cancer respond better to treatment than others

Researchers develop a prediction tool for blood cancer therapies

New and significant breakthrough made to detect brain tumors

Analyzing the role of ACSL4 in quadruple negative breast cancer

Revolution in neuroscience: 2D nanomaterials propel advances in brain repair, treatment, and diagnosis

Cost of prescription drugs to the NHS reached a new high in the financial year 2021 -2022, says LSE report

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News